GMVDF Statistics
Total Valuation
G Medical Innovations Holdings has a market cap or net worth of 26,442.
| Market Cap | 26,442 |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, September 13, 2024.
| Earnings Date | Sep 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
G Medical Innovations Holdings has 264.42 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 264.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +80.24% |
| Owned by Insiders (%) | 33.25% |
| Owned by Institutions (%) | 0.02% |
| Float | 176.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -6.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -223.32% |
| Return on Capital (ROIC) | -1,087.35% |
| Revenue Per Employee | 52,619 |
| Profits Per Employee | -160,964 |
| Employee Count | 84 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 11.24 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.62% in the last 52 weeks. The beta is -1.45, so G Medical Innovations Holdings's price volatility has been lower than the market average.
| Beta (5Y) | -1.45 |
| 52-Week Price Change | -99.62% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 57.49 |
| Average Volume (20 Days) | 2,661 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, G Medical Innovations Holdings had revenue of 4.42 million and -13.52 million in losses. Loss per share was -18.76.
| Revenue | 4.42M |
| Gross Profit | 784,000 |
| Operating Income | -27.41M |
| Pretax Income | -13.94M |
| Net Income | -13.52M |
| EBITDA | -26.65M |
| EBIT | -27.41M |
| Loss Per Share | -18.76 |
Balance Sheet
The company has 295,000 in cash and 2.09 million in debt, giving a net cash position of -1.80 million or -0.01 per share.
| Cash & Cash Equivalents | 295,000 |
| Total Debt | 2.09M |
| Net Cash | -1.80M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -4.57M |
| Book Value Per Share | -4.82 |
| Working Capital | -7.12M |
Cash Flow
In the last 12 months, operating cash flow was -18.48 million and capital expenditures -2.12 million, giving a free cash flow of -20.60 million.
| Operating Cash Flow | -18.48M |
| Capital Expenditures | -2.12M |
| Free Cash Flow | -20.60M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | 17.74% |
| Operating Margin | -620.14% |
| Pretax Margin | -315.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
G Medical Innovations Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -122.18% |
| Shareholder Yield | -122.18% |
| Earnings Yield | -18,756,918.00% |
| FCF Yield | -77,907.25% |
Stock Splits
The last stock split was on November 21, 2022. It was a reverse split with a ratio of 0.0285714.
| Last Split Date | Nov 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0285714 |
Scores
G Medical Innovations Holdings has an Altman Z-Score of -51.95. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -51.95 |
| Piotroski F-Score | n/a |